SCHEMBL4885771

SCHEMBL4885771

COC(=O)C(C)=CC1([SiH3])CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3459542 0.81
SCHEMBL28984387 0.78 TSHR (0.43)
SCHEMBL28384364 0.77
SCHEMBL9615569 0.75
SCHEMBL2641198 0.75
SCHEMBL4628092 0.75
SCHEMBL5175008 0.71
Oxalic Acid SCHEMBL29011315 0.71
SCHEMBL29117785 0.70 CYP3A4 (0.35)
SCHEMBL27598235 0.70 CYP3A4 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101291816-B Set of curable liquids and methods for inkjet printing AGFA GRAPHICS NV 2012-06-20 CN disclosed
US-20080268045-A1 SUSTAINED RELEASE METHOTREXATE FORMULATIONS AND METHODS OF USE THEREOF PROPRIUS PHARMACEUTICALS, INC. (US) 2008-10-30 US disclosed
WO-2008058288-A2 SUSTAINED RELEASE METHOTREXATE FORMULATIONS AND METHODS OF USE THEREOF PROPRIUS PHARMACEUTICALS, INC. (US) 2008-05-15 WO disclosed